Which and How Many Patients Should Be Included in Randomised Controlled Trials to Demonstrate the Efficacy of Biologics in Primary Sjögren’s Syndrome?

Overview of attention for article published in PLOS ONE, September 2015

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 8,652 followers.

RT @SjogrensCa: Which Patients Do We include? RCTs to Demonstrate the Efficacy of Biologics in Primary Sjögrens? http://t.co/tiD383YEuP #sj…

Which Patients Do We include? RCTs to Demonstrate the Efficacy of Biologics in Primary Sjögrens? http://t.co/tiD383YEuP #sjogrens #rheum

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.